Health Canada approves OPDIVO? (nivolumab) for the treatment of advanced or metastatic non-small cell lung cancer
OPDIVO™ is the first and only immuno-oncology therapy in lung cancer in Canada, which uses the body's own immune system to fight cancer, offering improved survival to more patients MONTREAL,...
Read More